Home
>
National Drug Code (NDC)
>
Pegasys
Pegasys - 0004-0357-99 - (peginterferon alfa-2a)
Drug Information of Pegasys
| Product NDC: | 0004-0357 |
| Proprietary Name: | Pegasys |
| Non Proprietary Name: | peginterferon alfa-2a |
| Active Ingredient(s): | 180 ug/.5mL & nbsp; peginterferon alfa-2a |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pegasys
| Product NDC: | 0004-0357 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103964 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110329 |
Package Information of Pegasys
| Package NDC: | 0004-0357-99 |
| Package Description: | 1 PACKET in 1 BOX (0004-0357-99) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS |
NDC Information of Pegasys
| NDC Code | 0004-0357-99 |
| Proprietary Name | Pegasys |
| Package Description | 1 PACKET in 1 BOX (0004-0357-99) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS |
| Product NDC | 0004-0357 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | peginterferon alfa-2a |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20110329 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | PEGINTERFERON ALFA-2A |
| Strength Number | 180 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] |
